Demonising Justin Gatlin
13th September 2015
USADA announced today that Ivan Shtyrkov, of Kosulino, Russia, has accepted a two-year sanction for a violation of the UFC® Anti-Doping Policy after testing positive for a prohibited substance. Shtyrkov, 31, who was added to the UFC roster in the middle of March, had two out-of-competition urine samples collected on March 27, 2019 and April 3, 2019 reported as atypical shortly before he was scheduled to compete in a UFC bout.
USADA notified the UFC of the laboratory’s initial atypical findings, and out of an abundance of caution, the UFC removed Shtyrkov from the card in which he was scheduled to compete. After conducting additional analysis, the laboratory reported both Shtyrkov’s samples as positive for boldenone and its metabolite 5β-androst-1-en-17β-ol-3-one.
Confirmation of the positive tests was achieved using the sensitive isotope ratio mass spectrometry (GC/C/IRMS) method, which reported laboratory results consistent with the exogenous origin of boldenone and its metabolite. Boldenone is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. Shtyrkov’s two-year period of ineligibility began on March 27, 2019, the date his positive sample was collected.
• This media release was published by the Ultimate Fighting Championships (UFC) and the US Anti-Doping Agency (USADA) on 9 July 2019. Click here for the original.
• KV Mechelen has said that it will lodge a complaint with FIFA alleging unilateral...
• Kelly Lindsey and Khalida Popal, Coach and Program Director of the Afghanistan women’s national...
The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of Rugby Australia to impose...